It was a pleasure to read the article from Verret et al. in a recent issue of Anesthesiology.1 The main prerequisites of a high-quality systematic review were met; however, some considerations about the patient, intervention, comparison, and study design approach applied and the conclusion of the review must be addressed. The main outcomes of the meta-analysis pooled results of highly divergent procedures, from endoscopic procedures to major surgeries. A relevant issue in both the Enhanced Recovery after Surgery and the Perioperative Surgical Home doctrines is the specificity of surgical route standardization.2,3 The possibility of another analgesic regiment being used in the comparator group is another concern. The use of gabapentin was compared with antidepressants, opioids, ketamine, nonsteroidal anti-inflammatory drugs, corticosteroids, benzodiazepines, neuroleptics, anticonvulsant, α2-adrenergic receptor agonists, paracetamol, melatonin, and placebo....
Skip Nav Destination
Correspondence| January 2021
Perioperative Use of Gabapentinoids: Comment
Bruno Luís de Castro Araujo, M.D., M.Sc., E.D.A.I.C.
Hospital do Câncer II, National Cancer Institute of Brazil (INCA), Rio de Janeiro, Brazil. firstname.lastname@example.org
Accepted for publication December 7, 2020
Anesthesiology Newly Published on January 2021. doi:
- Views Icon Views
- Share Icon Share
- Search Site
Bruno Luís de Castro Araujo; Perioperative Use of Gabapentinoids: Comment. Anesthesiology Newly Published on January 6, 2021. doi: https://doi.org/10.1097/ALN.0000000000003666
Download citation file:
Citing articles via
Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018: A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology